Data presented as part of a poster at the SITC 2024 ConferenceSOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics ...

LOUISVILLE, Ky. -- Minimally invasive ablative therapy for early kidney cancer had an increased risk of local and metastatic ...

Clinical update from ongoing MP0533 phase 1/2a dose escalation study confirms overall acceptable safety profile observed so far and initial ...

About five percent of cancers are genetically linked. Lifestyle factors play an even greater role. So what can you do to cut your cancer risk? We answer a viewer question from Afghanistan.

A discussion of these statements and risk factors is available on the current safe harbor ... where our STARS Safety Abstract ...

Pharmacokinetic Results: TX45 demonstrated a potential best-in-class half-life for a long-acting relaxin therapy. Final analysis showed that a single dose of TX45 had approximately 50% subcutaneous ...

In an online-only poster (e-poster), the company will present ... are described in greater detail in the section entitled “Risk Factors” in Bicycle’s Quarterly Report on Form 10-Q filed ...

Society of Immunotherapy of Cancer (SITC) poster to be presented by collaborator from Memorial ... the ability to initiate new clinical programs, the risk that the results of current preclinical ...

The reminders are everywhere. When a woman turns 40, doctors say she should begin receiving yearly mammograms to detect ...

Posters will be made available on the Kineta website following ... and those risks set forth under the caption “Risk Factors” in Kineta’s most recent Annual Report on Form 10-K filed with the SEC on ...

Today's poster presentation described the following key advantages ... as well as other risks described in "Risk Factors,” in ...